Dental Chairs And Equipment Market Outlook In Brics

By Author: Bharat Book Bureau
Total Articles: 1486
Comment this article

Country report, “PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis Event-Driven Update”. The RA market is currently very dynamic, with the November 6, 2012 FDA approval of Pfizer’s Xeljanz (tofacitinib) and novel oral therapies awaiting approval such as: Eli Lilly’s anti-BAFF, tabalumab and JAK1,2 inhibitor, baricitinib, and Rigel/AZ’s SYK inhibitor, fostamatinib. These compounds will challenge the current biologics in the attempt to dislodge the stronghold of the TNF inhibitors, if their safety and efficacy profiles are proven once they enter the market.

Indian physicians included in our study typically follow guidelines such as ACR or EULAR, but also follow their own clinical experience. In India, the process to diagnosis a patient with RA usually begins with the PCP or GP regardless of which potential stage the patient is in, then progresses with the referral to a rheumatologist for further diagnosis and treatment as this occurs about 32% of the time. Also, most people seeking treatment are within the 35-55-year-old group. Within this age group, females and males are equally distributed ...
... according to our physician experts. http://www.bharatbook.com/medical-devices-market-research-reports/dental-chairs-and-equipment-market-outlook-in-brics-brazil-russia-india-china-south-africato-2018.html

Scope

- Overview of RA, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in India including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in India from 2011 to 2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the India rheumatoid arthritis market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for rheumatoid arthritis
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of rheumatoid arthritis drug performance in India
 Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 15
2 Introduction 19
2.1 What is This Report About? 19
3 Dental Chairs and Equipment in BRICS 20
3.1 Dental Chairs and Equipment, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 20
3.2 Dental Chairs and Equipment, BRICS, Company share (2010-2011) 25
4 Dental Chairs and Equipment In Brazil 27
4.1 Dental Chairs and Equipment, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 27
4.2 Dental Chairs In Brazil 32
4.2.1 Dental Chairs, Brazil, Overall Revenue (2004-2018) 32
4.2.2 Dental Chairs, Brazil, Overall Volume (2004-2018) 34
4.2.3 Dental Chairs, Brazil, Average Price (2004-2018) 36
4.3 Motor Handpieces In Brazil 37
4.3.1 Motor Handpieces, Brazil, Overall Revenue (2004-2018) 37
4.3.2 Motor Handpieces, Brazil, Overall Volume (2004-2018) 39
4.3.3 Motor Handpieces, Brazil, Average Price (2004-2018) 41
4.4 Scaling Units In Brazil 42
4.4.1 Scaling Units, Brazil, Overall Revenue (2004-2018) 42
4.4.2 Scaling Units, Brazil, Overall Volume (2004-2018) 44
4.4.3 Scaling Units, Brazil, Average Price (2004-2018) 46
4.5 Light Cure Equipment In Brazil 47
4.5.1 Light Cure Equipment, Brazil, Overall Revenue (2004-2018) 47
4.5.2 Light Cure Equipment, Brazil, Overall Volume (2004-2018) 49
4.5.3 Light Cure Equipment, Brazil, Average Price (2004-2018) 51
- Obtain sales forecast from 2011-2022 in India
For more information kindly visit  : http://www.bharatbook.com/medical-devices-market-research-reports/dental-chairs-and-equipment-market-outlook-in-brics-brazil-russia-india-china-south-africato-2018.html

Or
Contact Us at:
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Call UK: +44 7405 208461
 Toll Free No for USA/Canada : 1-866-279-8368
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: https://twitter.com/researchbook
 Follow us on linkedin : http://www.linkedin.com/company/bharat-book-bureau
 Our Blog : http://blog.bharatbook.com/